The results showed increased levels of E-cadherin and Smad4 compared to N-cadherin and Vimentin; however, statistical analysis via paired t-test revealed no significant differences between E- and N-cadherin or among EMT markers and Smad4 between healthy and tumor tissues (Figure 3). The gene discussed is CDH2; the disease is neoplasm.